Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1979
mi
from 43215
Beverly Hills, CA
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1979
mi
from 43215
Beverly Hills, CA
Click here to add this to my saved trials
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1983
mi
from 43215
Los Angeles, CA
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1983
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
761
mi
from 43215
DeLand, FL
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
761
mi
from 43215
DeLand, FL
Click here to add this to my saved trials
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
424
mi
from 43215
Atlanta, GA
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
424
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
430
mi
from 43215
Decatur, GA
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
430
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1281
mi
from 43215
Santa Fe, NM
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1281
mi
from 43215
Santa Fe, NM
Click here to add this to my saved trials
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
752
mi
from 43215
Tulsa, OK
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
752
mi
from 43215
Tulsa, OK
Click here to add this to my saved trials
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
937
mi
from 43215
Fort Worth, TX
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
937
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
5386
mi
from 43215
Ciudad Autonoma de Buenos Aires,
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
5386
mi
from 43215
Ciudad Autonoma de Buenos Aires,
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Spectrum Medical Group
1660
mi
from 43215
Phoenix, AZ
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Spectrum Medical Group
1660
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Pacific Oaks Medical Group
1979
mi
from 43215
Beverly Hills, CA
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Pacific Oaks Medical Group
1979
mi
from 43215
Beverly Hills, CA
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
University of California, San Diego (UCSD)
1953
mi
from 43215
La Jolla, CA
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
University of California, San Diego (UCSD)
1953
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Anthony Mills MD Inc
1978
mi
from 43215
Los Angeles, CA
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Anthony Mills MD Inc
1978
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Peter J. Ruane, MD, Inc.
1977
mi
from 43215
Los Angeles, CA
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Peter J. Ruane, MD, Inc.
1977
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Highland Hospital/Alameda Health System
2097
mi
from 43215
Oakland, CA
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Highland Hospital/Alameda Health System
2097
mi
from 43215
Oakland, CA
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
La Playa Medical Group and Clinical Research
1951
mi
from 43215
San Diego, CA
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
La Playa Medical Group and Clinical Research
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Gary J. Richmond, M.D., P.A.
972
mi
from 43215
Fort Lauderdale, FL
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Gary J. Richmond, M.D., P.A.
972
mi
from 43215
Fort Lauderdale, FL
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Midway Immunology and Research Center
882
mi
from 43215
Fort Pierce, FL
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Midway Immunology and Research Center
882
mi
from 43215
Fort Pierce, FL
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Orlando Immunology Center
793
mi
from 43215
Orlando, FL
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Orlando Immunology Center
793
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Triple O Research Institute, P.A.
931
mi
from 43215
West Palm Beach, FL
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Triple O Research Institute, P.A.
931
mi
from 43215
West Palm Beach, FL
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Atlanta ID Group
432
mi
from 43215
Atlanta, GA
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Atlanta ID Group
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Howard Brown Health Center
277
mi
from 43215
Chicago, IL
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Howard Brown Health Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
University of Louisville
188
mi
from 43215
Louisville, KY
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
University of Louisville
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Be Well Medical Center
175
mi
from 43215
Berkley, MI
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Be Well Medical Center
175
mi
from 43215
Berkley, MI
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Hennepin County Medical Center
623
mi
from 43215
Minneapolis, MN
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Hennepin County Medical Center
623
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
KC Care Clinic
619
mi
from 43215
Kansas City, MO
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
KC Care Clinic
619
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Saint Michael's Medical Center
468
mi
from 43215
Newark, NJ
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Saint Michael's Medical Center
468
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
South Jersey Infectious Disease
450
mi
from 43215
Somers Point, NJ
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
South Jersey Infectious Disease
450
mi
from 43215
Somers Point, NJ
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Southwest CARE Center
1284
mi
from 43215
Santa Fe, NM
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Southwest CARE Center
1284
mi
from 43215
Santa Fe, NM
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Philadelphia FIGHT
416
mi
from 43215
Philadelphia, PA
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Philadelphia FIGHT
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Central Texas Clinical Research
1063
mi
from 43215
Austin, TX
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Central Texas Clinical Research
1063
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
AIDS Arms, Inc
910
mi
from 43215
Dallas, TX
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
AIDS Arms, Inc
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Tarrant County Infectious Disease Associates
937
mi
from 43215
Fort Worth, TX
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Tarrant County Infectious Disease Associates
937
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Gordon E. Crofoot MD PA
994
mi
from 43215
Houston, TX
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Gordon E. Crofoot MD PA
994
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Therapeutic Concepts, P.A.
993
mi
from 43215
Houston, TX
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Therapeutic Concepts, P.A.
993
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Peter Shalit, M.D.
2006
mi
from 43215
Seattle, WA
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Peter Shalit, M.D.
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
UZ Gent
4022
mi
from 43215
Ghent,
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
UZ Gent
4022
mi
from 43215
Ghent,
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Lsu Health Sciences Center
797
mi
from 43215
New Orleans, LA
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Lsu Health Sciences Center
797
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Therafirst Medical Center
970
mi
from 43215
Fort Lauderdale, FL
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Therafirst Medical Center
970
mi
from 43215
Fort Lauderdale, FL
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Southampton Healthcare, Inc.
399
mi
from 43215
Saint Louis, MO
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Southampton Healthcare, Inc.
399
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Capial Medical Associates
327
mi
from 43215
Washington,
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Capial Medical Associates
327
mi
from 43215
Washington,
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Dupont Circle Physician's Group
328
mi
from 43215
Washington,
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Dupont Circle Physician's Group
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Whitman Walker Health
328
mi
from 43215
Washington,
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Whitman Walker Health
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
Status: Enrolling
Updated:  12/31/1969
UCLA CARE Center CRS
1979
mi
from 43215
Los Angeles, CA
Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
Status: Enrolling
Updated: 12/31/1969
UCLA CARE Center CRS
1979
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
Status: Enrolling
Updated:  12/31/1969
Ucsf Hiv/Aids Crs
2107
mi
from 43215
San Francisco, CA
Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
Status: Enrolling
Updated: 12/31/1969
Ucsf Hiv/Aids Crs
2107
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Chelsea CRS
477
mi
from 43215
New York, NY
Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Chelsea CRS
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Uptown CRS
479
mi
from 43215
New York, NY
Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Uptown CRS
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
Status: Enrolling
Updated:  12/31/1969
Case Clinical Research Site
129
mi
from 43215
Cleveland, OH
Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
Status: Enrolling
Updated: 12/31/1969
Case Clinical Research Site
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
Status: Enrolling
Updated:  12/31/1969
Penn Therapeutics Crs
414
mi
from 43215
Philadelphia, PA
Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
Status: Enrolling
Updated: 12/31/1969
Penn Therapeutics Crs
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials